Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

High-throughput screening of the cyclic AMP-dependent protein kinase (PKA) using the caliper microfluidic platform.

Blackwell LJ, Birkos S, Hallam R, Van De Carr G, Arroway J, Suto CM, Janzen WP.

Methods Mol Biol. 2009;565:225-37. doi: 10.1007/978-1-60327-258-2_11.

PMID:
19551365
2.

Reading dynamic kinase activity in living cells for high-throughput screening.

Allen MD, DiPilato LM, Rahdar M, Ren YR, Chong C, Liu JO, Zhang J.

ACS Chem Biol. 2006 Jul 21;1(6):371-6.

PMID:
17163774
3.

Assay development and screening of a serine/threonine kinase in an on-chip mode using caliper nanofluidics technology.

Perrin D, Frémaux C, Scheer A.

J Biomol Screen. 2006 Jun;11(4):359-68. Epub 2006 Apr 28.

PMID:
16751332
4.

A high-throughput, nonisotopic, competitive binding assay for kinases using nonselective inhibitor probes (ED-NSIP).

Vainshtein I, Silveria S, Kaul P, Rouhani R, Eglen RM, Wang J.

J Biomol Screen. 2002 Dec;7(6):507-14.

PMID:
14599348
5.
6.

Micro- and nanofluidic systems for high-throughput biological screening.

Hong J, Edel JB, deMello AJ.

Drug Discov Today. 2009 Feb;14(3-4):134-46. doi: 10.1016/j.drudis.2008.10.001. Epub 2008 Dec 4. Review.

PMID:
18983933
7.

A generic high-throughput screening assay for kinases: protein kinase a as an example.

Mallari R, Swearingen E, Liu W, Ow A, Young SW, Huang SG.

J Biomol Screen. 2003 Apr;8(2):198-204.

PMID:
12844441
8.

Technological advances in high-throughput screening.

Liu B, Li S, Hu J.

Am J Pharmacogenomics. 2004;4(4):263-76. Review.

PMID:
15287820
9.

High-throughput screening for kinase inhibitors.

von Ahsen O, Bömer U.

Chembiochem. 2005 Mar;6(3):481-90. Review.

PMID:
15742384
10.

Polymeric nanoparticles for protein kinase activity.

Kim JH, Lee S, Kim K, Jeon H, Park RW, Kim IS, Choi K, Kwon IC.

Chem Commun (Camb). 2007 Apr 7;(13):1346-8. Epub 2007 Jan 12.

PMID:
17377677
11.

Process validation and screen reproducibility in high-throughput screening.

Coma I, Clark L, Diez E, Harper G, Herranz J, Hofmann G, Lennon M, Richmond N, Valmaseda M, Macarron R.

J Biomol Screen. 2009 Jan;14(1):66-76. doi: 10.1177/1087057108326664.

PMID:
19171922
12.

Fission yeast-based high-throughput screens for PKA pathway inhibitors and activators.

de Medeiros AS, Kwak G, Vanderhooft J, Rivera S, Gottlieb R, Hoffman CS.

Methods Mol Biol. 2015;1263:77-91. doi: 10.1007/978-1-4939-2269-7_6.

PMID:
25618337
13.

Mass spectrometric techniques for label-free high-throughput screening in drug discovery.

Roddy TP, Horvath CR, Stout SJ, Kenney KL, Ho PI, Zhang JH, Vickers C, Kaushik V, Hubbard B, Wang YK.

Anal Chem. 2007 Nov 1;79(21):8207-13. Epub 2007 Sep 29.

PMID:
17902631
14.

Plate-based diversity selection based on empirical HTS data to enhance the number of hits and their chemical diversity.

Sukuru SC, Jenkins JL, Beckwith RE, Scheiber J, Bender A, Mikhailov D, Davies JW, Glick M.

J Biomol Screen. 2009 Jul;14(6):690-9. doi: 10.1177/1087057109335678. Epub 2009 Jun 16.

PMID:
19531667
15.

Development of a microplate-based, electrophoretic fluorescent protein kinase a assay: comparison with filter-binding and fluorescence polarization assay formats.

Miick SM, Jalali S, Dwyer BP, Havens J, Thomas D, Jimenez MA, Simpson MT, Zile B, Huss KL, Campbell RM.

J Biomol Screen. 2005 Jun;10(4):329-38.

PMID:
15964934
16.

Comparison of on-chip and off-chip microfluidic kinase assay formats.

Dunne J, Reardon H, Trinh V, Li E, Farinas J.

Assay Drug Dev Technol. 2004 Apr;2(2):121-9.

PMID:
15165508
18.

Discovery of highly selective inhibitors of p38alpha.

Popa-Burke I, Birkos S, Blackwell L, Cheatham L, Clark J, Dickson JK Jr, Galasinski S, Janzen WP, Mendoza J, Miller JL, Mohney RP, Steed PM, Hodge CN.

Curr Top Med Chem. 2005;5(10):941-51. Review.

PMID:
16178739
19.

Miniaturized microfluidic formats for cell-based high-throughput screening.

Upadhaya S, Selvaganapathy PR.

Crit Rev Biomed Eng. 2009;37(3):193-257. Review.

PMID:
20402621
20.

Delineation of selective cyclic GMP-dependent protein kinase Ialpha substrate and inhibitor peptides based on combinatorial peptide libraries on paper.

Dostmann WR, Nickl C, Thiel S, Tsigelny I, Frank R, Tegge WJ.

Pharmacol Ther. 1999 May-Jun;82(2-3):373-87.

PMID:
10454213

Supplemental Content

Support Center